Open access · CC-BY
via OpenAlex
Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity
Yasser Iturria‐Medina, Quadri Adewale, Ahmed Faraz Khan, Simon Ducharme, Pedro Rosa‐Neto, Kieran J. O’Donnell, Vladislav Petyuk, Serge Gauthier, Philip L. De Jager, John C.S. Breitner, David A. Bennett
Science Advances · 2022 · ▲ 102 citations
Abstract
Alzheimer’s disease (AD) is a heterogeneous disorder with abnormalities in multiple biological domains. In an advanced machine learning analysis of postmortem brain and in vivo blood multi-omics molecular data ( N = 1863), we integrated epigenomic, transcriptomic, proteomic, and metabolomic profiles into a multilevel biological AD taxonomy. We obtained a personalized multilevel molecular index of AD dementia progression that predicts severity of neuropathologies, and identified three robust molecular-based subtypes that explain much of the pathologic and clinical heterogeneity of AD. These subtypes present distinct patterns of alteration in DNA methylation, RNA, proteins, and metabolites, identifiable in the brain and subsequently in blood. In addition, the genetic variations that predispose to the various AD subtypes in brain predict distinct spatial patterns of alteration in cell types, suggesting a unique influence of each putative AD variant on neuropathological mechanisms. These observations support that an individually tailored multi-omics molecular taxonomy of AD may represent distinct targets for preventive or treatment interventions.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1126/sciadv.abo6764
- Canonical
- link ↗
- Fetched
- 2026-09-16 MST
Cite this
APA
Iturria‐Medina, Y., Adewale, Q., Khan, A.F., Ducharme, S., Rosa‐Neto, P., O’Donnell, K.J., Petyuk, V., Gauthier, S., Jager, P.L.D., Breitner, J.C., & Bennett, D.A. (2022). Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity. <em>Science Advances</em>. https://doi.org/10.1126/sciadv.abo6764
Vancouver
Iturria‐Medina Y, Adewale Q, Khan AF, Ducharme S, Rosa‐Neto P, O’Donnell KJ, et al. Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity. Science Advances. 2022. doi:10.1126/sciadv.abo6764.
BibTeX
@article{yasser2022Unifie,
title = {Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity},
author = {Yasser Iturria‐Medina and Quadri Adewale and Ahmed Faraz Khan and Simon Ducharme and Pedro Rosa‐Neto and Kieran J. O’Donnell and Vladislav Petyuk and Serge Gauthier and Philip L. De Jager and John C.S. Breitner and David A. Bennett},
journal = {Science Advances},
year = {2022},
doi = {10.1126/sciadv.abo6764},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Trends in Endocrinology and Metabolism 2014
Citation only
Epigenetic modifiers of islet function and mass
The American Journal of Cardiology 2016
Citation only
Cardiac Structure and Function and Frailty in Subjects Aged 85 and 86 Years
medRxiv 2026
Preprint · CC-BY
Peripheral Epigenetic Aging Predicts Survival in Cognitively Healthy Centenarians Independent of Brain Aging-Related Biomarkers
Alzheimer s Research & Therapy 2021
Open access · CC-BY
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
Communications Medicine 2025
Open access · CC-BY
Plasma-based brain age as a potential biomarker for cognitive health and risk of brain-related disorders
Dementia & Neuropsychologia 2016
Open access · CC-BY